Life

Health, science, climate, and society-focused reporting.

Eli Lilly Highlights Societal Role of GLP-1 Medications Amid Biotech Developments

Eli Lilly underscores the critical role of GLP-1 medications in healthcare, while also noting Merck's acquisition of Terns Pharma and other biotech advancements.

Editorial Staff Mar 25

Life

Merck's $6.7 Billion Acquisition of Terns Pharmaceuticals: Implications for Oncology Infrastructure

Merck's acquisition of Terns Pharmaceuticals for $6.7 billion is a strategic move to bolster its oncology portfolio, particularly in leukemia treatment.

Editorial Staff Mar 25

Life

Enhancing Emergency Room Safety for Dementia Patients: Key Considerations

Recent discussions highlight the need for improved safety measures in emergency rooms for individuals with dementia. This includes addressing communication barriers and environmental adaptations.

Editorial Staff Mar 25

Life

KFF Poll Indicates Shift Towards AI for Health Information Among Adults

A recent KFF poll reveals that adults are increasingly turning to AI for health advice, mirroring their reliance on social media, influenced by healthcare costs and access issues.

Editorial Staff Mar 25

Life

Growing Adoption of AI Chatbots for Health Queries: 32% of Adults Engaged

A recent KFF Tracking Poll indicates that 32% of adults have utilized AI chatbots for health information, paralleling social media usage for similar inquiries.

Editorial Staff Mar 25

Life

Growing Adoption of AI Chatbots for Health Information Among Adults

A recent KFF Tracking Poll indicates that 32% of adults have utilized AI chatbots for health information, paralleling social media usage for similar inquiries.

Editorial Staff Mar 25

Life

Departure of Federal Vaccine Adviser Highlights Regulatory Challenges

Robert Malone's exit from the Advisory Committee on Immunization Practices (ACIP) follows a federal judge's ruling that halted the panel's operations, raising questions about vaccine advisory processes.

Editorial Staff Mar 24

Life

Abortion-related Ballot Initiatives Post-Dobbs: A State-Level Overview

Since the Dobbs decision, 17 states have engaged in ballot measures concerning abortion, reflecting significant shifts in state policies. Upcoming votes in Missouri and Nevada are scheduled for November 2026.

Editorial Staff Mar 24

Life

Abortion-Related Ballot Initiatives: Analyzing Post-Dobbs Trends Across States

Since the Dobbs decision, 17 states have engaged in ballot measures concerning abortion, indicating varying state-level responses and infrastructure implications.

Editorial Staff Mar 24

Life

CMS Initiates Pilot Program for Children with Complex Health Needs

The Centers for Medicare and Medicaid Services (CMS) is launching a pilot program aimed at integrating care for children with complex health conditions, led by Administrator Mehmet Oz.

Editorial Staff Mar 24

Life

FTC Settlement with CVS Targets Insulin Price Manipulation

The FTC's proposed settlement with CVS aims to address allegations of price manipulation by its pharmacy benefit manager, potentially saving consumers $7 billion over the next decade.

Editorial Staff Mar 24

Life

Analysis Reveals Minimal Financial Impact of Drug Company Kickback Penalties

An analysis indicates that drugmakers penalized for kickbacks paid only 2.2% of their U.S. revenue from the implicated drugs over the past 25 years.

Editorial Staff Mar 24

Life

FDA Criticizes ImmunityBio's Claims on Cancer Treatment

The FDA has issued a strong rebuke to Patrick Soon-Shiong and ImmunityBio, citing false and misleading claims regarding a cancer treatment's efficacy.

Editorial Staff Mar 24

Life

Implications of Trump's Approach to CDC and ACIP

Trump's forthcoming decisions regarding the CDC and ACIP could significantly influence public health policy and operational frameworks, reflecting the impact of RFK Jr.'s MAHA movement.

Editorial Staff Mar 24

Life

2024 ACA Marketplace Claims Denials: Infrastructure Challenges Identified

An analysis of claims denials in the ACA Marketplace highlights significant operational challenges, with insurers denying 19% of in-network claims in 2024.

Editorial Staff Mar 24

Life

Deepfake X-rays Pose Risks to Medical Imaging Integrity

The emergence of deepfake technology in medical imaging raises significant concerns regarding diagnostic accuracy and patient care. Researchers warn that these manipulated images could disrupt healthcare delivery.

Editorial Staff Mar 24

Life

AI Doctor Startup Secures Funding and Plans FDA Engagement

An AI doctor startup has successfully raised new capital and is preparing to engage with the FDA, indicating a significant step towards regulatory compliance and market entry.

Editorial Staff Mar 24

Life

Understanding the BALANCE Model for GLP-1s in Medicare and Medicaid

This brief outlines the current coverage of GLP-1s in Medicare and Medicaid, focusing on CMS's BALANCE model aimed at enhancing access and reducing costs.

Editorial Staff Mar 24

Life

Gilead's Acquisition of Immunology Biotech: Implications for Galapagos

Gilead's acquisition of an immunology biotech provides critical support for Galapagos, highlighting strategic moves in the biopharmaceutical landscape.

Editorial Staff Mar 24

Life

Analysis of Drug Pricing Reforms and Gilead's New Deal

Recent comments from a senior health official during the Trump administration reveal critical flaws in the proposed most-favored nation drug pricing plan, alongside insights into Gilead's latest deal.

Editorial Staff Mar 24